PIK3C3 and neoplasm: Flow cytometry profiling revealed a significantly reduced proportion of Vps34-deficient (GFP+YFP+) Tregs in the tumor (and modest reduction in the spleen) of tamoxifen-treated Foxp3Cre-ERT2Pik3c3fl/fl mice compared to control counterparts (Fig 7C).